While PMCA2 (ATP2B2) was upregulated in HER+ breast cancer tumors [23], PMCA4 (ATP2B4) was downregulated in colon and prostate cancers, and lymph node metastases in contrast to the relatively high PMCA4 protein level in normal tissues [24,25]. Here, ATP2B4 is linked to prostate cancer.